-
Something wrong with this record ?
Cognitive impairment in bipolar disorder
Klara Latalova, Jan Prasko, Tomas Diveky, Hana Velartova
Language English Country Czech Republic
Document type Review
Grant support
NT11047
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
- MeSH
- Bipolar Disorder drug therapy complications psychology MeSH
- Financing, Organized MeSH
- Cognition drug effects MeSH
- Cognition Disorders complications MeSH
- Humans MeSH
- Check Tag
- Humans MeSH
- Publication type
- Review MeSH
Aim. Provide an overview of how bipolar disorder affects cognitive function in patients. Methods. MEDLINE and PsycInfo data bases were searched for articles indexed by the combinations of MESH term or key word "bipolar disorder" with the following terms: "cognition", "memory", "neuropsychology", "neuropsychological tests", "lithium", "anticonvulsants", "antipsychotics", and "schizophrenia". Constraints limiting time period of publications or their language were not applied. Reference lists of publications identified by these procedures were hand-searched for additional relevant citations. Results. There is evidence of stable and lasting cognitive impairment in all phases of bipolar disorder, including the remission phase, particularly in the following domains: sustained attention, memory and executive functions. But research on the cognitive functions has yielded inconsistent results over recent years. There is a growing need for clarification regarding the magnitude, clinical relevance and confounding variables of cognitive impairment in bipolar patients. The impact of bipolar illness on cognition can be influenced by age of onset, pharmacological treatments, individual response, familial risk factors, and clinical features. In addition to the mood state, cognitive performance in bipolar patients is influenced by seasonality. Conclusion. Previous optimistic assumptions about the prognosis of bipolar disorder were based on the success of the control of mood symptoms by pharmacotherapy. However, it is now clear that the "remitted" euthymic bipolar patients have distinct impairments of executive function, verbal memory, psychomotor speed, and sustained attention. Mood stabilizers and atypical antipsychotics may reduce cognitive deficits in certain domains and may have a positive effect on quality of life and social functioning.
References provided by Crossref.org
Lit.: 59
- 000
- 00000naa 2200000 a 4500
- 001
- bmc11010887
- 003
- CZ-PrNML
- 005
- 20141111165058.0
- 008
- 110519s2011 xr e eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.155.2011.003 $2 doi
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Látalová, Klára, $d 1970- $7 nlk20030127630 $u Department of Psychiatry, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Czech Republic
- 245 10
- $a Cognitive impairment in bipolar disorder / $c Klara Latalova, Jan Prasko, Tomas Diveky, Hana Velartova
- 314 __
- $a Department of Psychiatry, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Czech Republic. klaralat@centrum.cz.
- 504 __
- $a Lit.: 59
- 520 9_
- $a Aim. Provide an overview of how bipolar disorder affects cognitive function in patients. Methods. MEDLINE and PsycInfo data bases were searched for articles indexed by the combinations of MESH term or key word "bipolar disorder" with the following terms: "cognition", "memory", "neuropsychology", "neuropsychological tests", "lithium", "anticonvulsants", "antipsychotics", and "schizophrenia". Constraints limiting time period of publications or their language were not applied. Reference lists of publications identified by these procedures were hand-searched for additional relevant citations. Results. There is evidence of stable and lasting cognitive impairment in all phases of bipolar disorder, including the remission phase, particularly in the following domains: sustained attention, memory and executive functions. But research on the cognitive functions has yielded inconsistent results over recent years. There is a growing need for clarification regarding the magnitude, clinical relevance and confounding variables of cognitive impairment in bipolar patients. The impact of bipolar illness on cognition can be influenced by age of onset, pharmacological treatments, individual response, familial risk factors, and clinical features. In addition to the mood state, cognitive performance in bipolar patients is influenced by seasonality. Conclusion. Previous optimistic assumptions about the prognosis of bipolar disorder were based on the success of the control of mood symptoms by pharmacotherapy. However, it is now clear that the "remitted" euthymic bipolar patients have distinct impairments of executive function, verbal memory, psychomotor speed, and sustained attention. Mood stabilizers and atypical antipsychotics may reduce cognitive deficits in certain domains and may have a positive effect on quality of life and social functioning.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a bipolární porucha $x farmakoterapie $x komplikace $x psychologie $7 D001714
- 650 _2
- $a kognice $x účinky léků $7 D003071
- 650 _2
- $a kognitivní poruchy $x komplikace $7 D003072
- 650 _2
- $a lidé $7 D006801
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Praško, Ján, $d 1956- $7 jn20000402046 $u Department of Psychiatry, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Czech Republic; Prague Psychiatric Centre, Praha; Centre of Neuropsychiatric Studies, Praha
- 700 1_
- $a Divéky, Tomáš $7 xx0161108 $u Department of Psychiatry, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Czech Republic
- 700 1_
- $a Velartová, Hana. $7 _AN060264 $u Department of Psychiatry, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Czech Republic
- 773 0_
- $w MED00012606 $t Biomedical papers $g Roč. 155, č. 1 (2011), s. 19-26 $x 1213-8118
- 856 41
- $u http://biomed.papers.upol.cz/pdfs/bio/2011/01/03.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 1 $z 0
- 990 __
- $a 20110518141529 $b ABA008
- 991 __
- $a 20141111165111 $b ABA008
- 999 __
- $a ok $b bmc $g 840306 $s 704341
- BAS __
- $a 3
- BMC __
- $a 2011 $b 155 $c 1 $d 19-26 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $x MED00012606
- GRA __
- $a NT11047 $p MZ0
- LZP __
- $a 2011-08/mkme